How knowledge time influenced anxiety, depression, stress and quality of life levels in patients suffering from Crohn disease: a cross-sectional multicenter study Anxiety, depression, stress and quality of life levels in patients suffering from Crohn disease
Main Article Content
Anxiety, Crohn Disease, Depression, Quality of Life, Stress
Background and aim of the work. The diagnosis of Crohn Disease (CD) represents a turning point in the life of patients, which inevitably marks them. The present study represents a direct "feed-back" from patients suffering from Crohn disease, in order to reveal how the diagnosis of CD changed lifestyles and psychological conditions in their patients. Methods. An observational, cross sectional, online, snowball sampling study was conducted through participants suffered from CD and belonged to social networks and Facebook groups. For each participant, sampling characteristics, a series of lifestyle habits Before to After the diagnosis of CD and anxiety, depression, and stress conditions were investigated. Results. A total of 785 participants agreed to participate. As Participants underwent significant challenges in their lifestyles after the CD diagnosis (p<0.001), specifically their reduced their smoking habits, alcohol and drugs intakes and also their diets both in high sugar and fatty compositions. Anxiety and stress levels were not statistical different among participants according to years of the knowledge of their CDs. Meanwhile, as regards depression condition, significantly higher levels were recorded among participants who knew their CD until 5 and 25 years, respectively (p=0.031). Conclusions. From the study emerges several aspects of quality of life compromised, a fact supported by the analysis of psychophysical sequelae, which allowed to lay the groundwork for further studies, studying the comorbidity of this disease with other factors. Future randomized controlled trials should deepen the correlation between eating disorders and CD, a link little explored in the literature.
1. Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep 2019; 21: 40.
2. Zhao M, Gönczi L, Lakatos PL, Burisch J. The Burden of Inflammatory Bowel Disease in Europe in 2020. J Crohns Colitis 2021; 15(9):1573-1587.
3. Biancone L, Vernia P. Morbo di Crohn. Schede pratiche sull’alimentazione nelle malattie digestive 2018; 19.
4. Kim YS, Jung SA, Lee KM, et al., Korean Association for the Study of Intestinal Diseases (KASID). Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases. Intest Res. 2017; 15(3):338-344.
5. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2009; 104(2):465-83.
6. Varma A, Weinstein J, Seabury J, et al. Patient-Reported Impact of Symptoms in Crohn's Disease. Am J Gastroenterol. 2022; 117(12):2033-2045.
7. AlQahtani M, AlHarbi R, AlAsmari R, AlNowaiser L, AlThunayan E, Alzaben AS. Health-Related Quality of Life in Individuals with Crohn's Disease: A Sample from Saudi Arabia. J Allied Health. 2022; 51(2):104-109.
8. Engel F, Berens S, Gauss A, Schaefert R, Eich W, Tesarz J. Higher Levels of Psychological Burden and Alterations in Personality Functioning in Crohn's Disease and Ulcerative Colitis. Front Psychol. 2021; 12:671493.
9. Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021; 6(5):359-370.
10. van den Brink G, Stapersma L, El Marroun H, et al. Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD). BMJ Open Gastroenterol. 2016; 3(1):e000071.
11. Pittet V, Vaucher C, Froehlich F, Burnand B, Michetti P, Maillard MH, Swiss IBD Cohort Study Group. Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator. PLoS One. 2017; 12(2):e0171864.
12. Häuser W, Janke KH, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis. 2011; 17(2):621-32.
13. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis. 2007; 13(2):225-34.
14. Shen H, Zhang Z-P, Li J-H. An Efficient Palladium-Catalysed Amination of Aryl Chlorides in Presence of 1,3-bis-(2,6-Diisopropylphenyl) Imidazolinium Chloride. Journal of Chemical Research. 2010; 34(3):163-166.
15. Song JH, Kim JW, Oh CH, Kim HJ, Lee CK, Kang WS. Depression, Anxiety, Related Risk Factors and Cognitive Distortion in Korean Patients with Inflammatory Bowel Disease. Psychiatry Investig 2020; 17(11):1126-1136.
16. Xiong Q, Tang F, Li Y, et al. Association of inflammatory bowel disease with suicidal ideation, suicide attempts, and suicide: A systematic review and meta-analysis. J Psychosom Res 2022; 160:110983.
17. Xiong Q, Tang F, Li Y, Xie F, Yuan L, Yao C, Wu R, Wang J, Wang Q, Feng P. Association of inflammatory bowel disease with suicidal ideation, suicide attempts, and suicide: A systematic review and meta-analysis. J Psychosom Res. 2022; 160:110983.
18. Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003;42(Pt 2):111-31.
19. Rozich JJ, Holmer A, Singh S. Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases. Am J Gastroenterol 2020; 115(6):832-840.
20. Czuber-Dochan W, Morgan M, Hughes LD, Lomer MCE, Lindsay JO, Whelan K. Perceptions and psychosocial impact of food, nutrition, eating and drinking in people with inflammatory bowel disease: a qualitative investigation of food-related quality of life. J Hum Nutr Diet. 2020; 33(1):115-127.
21. Wang P, Hu J, Ghadermarzi S, et al. Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA. Dig Dis Sci. 2018; 63(10):2703-2713.
22. Gao N, Qiao Z, Yan S, Zhu L. Evaluation of health-related quality of life and influencing factors in patients with Crohn disease. Journal of International Medical Research. 2022; 50(5).
23. Nahon S, Lahmek P, Durance C. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2086–91
24. Häuser W, Janke KH, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011; 17: 621–32
25. Panara AJ, Yarur AJ, Rieders B, et al. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharmacol Ther. 2014; 39(8):802-10.
26. Hauser G, Tkalcić M, Stimac D, Milić S, Sincić BM. Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Coll Antropol. 2011; 35 Suppl 2:203-7.
27. Caplan RA, Maunder RG, Stempak JM, Silverberg MS, Hart TL. Attachment, Childhood Abuse, and IBD-related Quality of Life and Disease Activity Outcomes. Inflammatory Bowel Diseases 2014; 20(5), 909–915.
28. Nishida Y, Hosomi S, Fujimoto K, et al. Impact of the lockdown due to the Covid-19 pandemic on patients with inflammatory bowel disease. Front. Med. 2020; 8: 64975
29. Choi K, Chun J, Han K, et al. Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study. J Clin Med. 2019; 8(5):654.
30. Larsson K, Lööf L, Nordin K. Stress, coping and support needs of patients with ulcerative colitis or Crohn's disease: a qualitative descriptive study. J Clin Nurs 2017; 26: 648-657.
31. Gao X, Tang Y, Lei N, et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease. Sci Rep. 2021; 11(1):1440.
32. Gaines LS, Slaughter JC, Horst SN, et al. Association Between Affective-Cognitive Symptoms of Depression and Exacerbation of Crohn's Disease. Am J Gastroenterol 2016; 111(6):864-70.
33. Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis 2018; 24(4):742-751.
34. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006;12(8):697–707.
35. Ludvigsson JF, Olén O, Larsson H, et al. Association Between Inflammatory Bowel Disease and Psychiatric Morbidity and Suicide: A Swedish Nationwide Population-Based Cohort Study With Sibling Comparisons. J Crohns Colitis. 2021; 15(11):1824-1836.
36. Zhang C, Byrne G, Lee T, Singer J, Giustini D, Bressler B. Incidence of Suicide in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Can Assoc Gastroenterol. 2018; 1(3):107-114.
37. Shayowitz M, Bressler M, Ricardo AP, Grudnikoff E. Infliximab-induced Depression and Suicidal Behavior in Adolescent with Crohn's Disease: Case Report and Review of Literature. Pediatr Qual Saf. 2019; 4(6):e229.
38. Catalán-Serra I, Huguet-Malavés JM, Mínguez M, et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterol Hepatol. 2015; 38(6):355-63.
39. Hayes B, Appunthurai, P, Mikocka-Walus A, et al. Extending the Common Sense Model to explore the impact of the fear of Covid-19 on quality of life in an international inflammatory bowel disease Cohort. Journal of clinical psychology in medical settings 2021; 29, 678-688
40. Lores T, Goess C, Mikocka-Walus A, et al. Integrated Psychological Care is Needed, Welcomed and Effective in Ambulatory Inflammatory Bowel Disease Management: Evaluation of a New Initiative. J Crohns Colitis. 2019; 13(7):819-827.